Sleep Disorders Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People aged 18 or older, of any gender
• People who have been diagnosed with a mental health condition of any type, based on standard diagnostic guidelines (called DSM-5)
• People whose insomnia has been rated at a score of 11 or higher on a standard sleep questionnaire called the Insomnia Severity Index (ISI)
• People who have at least 7 hours available for sleep each night
• People who are able to attend assessments and follow-up appointments over a 2-month period
• People who have agreed to take part and signed a consent form
• People whose treating doctor has determined that the sleep medication lemborexant is an appropriate treatment option for them

Who may not be able to join:

• People whose mental health condition is currently in an acute (severe or crisis) phase, or whose other psychiatric medications cannot be kept at a stable dose during the study
• People currently using two or more different medications from a group of sleep drugs known as benzodiazepine receptor agonists (BZRAs) at the same time
• People who have previously used a type of sleep medication called a dual orexin receptor antagonist (DORA) continuously for more than one week (confirm with trial site)
• People assessed by the research team as having a clear suicide attempt, plan, or high suicide risk
• People who are pregnant or breastfeeding
• People who have a condition called narcolepsy (a sleep disorder involving uncontrollable episodes of sleep)
• People who have severe liver disease or liver failure
• People who currently have severe or unstable heart, lung, digestive, or other serious health conditions
• People the research team considers unsuitable for any other reason

Important: Always verify eligibility with the trial site directly before applying.